Scanning Electron Microscopy Visualization of Methicillin-Resistant Staphylococcus aureus After Contact With Gatifloxacin With and Without Preservative

Besifloxacin, a Novel Fluoroquinolone, Has Broad-Spectrum In Vitro Activity against Aerobic and Anaerobic Bacteria

(2009) W. Haas et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Phase III efficacy and safety study of besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis

(2009) Michael E. Tepedino et al.   CURRENT MEDICAL RESEARCH AND OPINION

Benzalkonium Chloride Enhances Antibacterial Activity of Gatifloxacin and Reduces its Propensity to Select for Fluoroquinolone-Resistant Strains

(2009) Christine K. Hesje et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Efficacy and Safety of Besifloxacin Ophthalmic Suspension 0.6% Compared with Moxifloxacin Ophthalmic Solution 0.5% for Treating Bacterial Conjunctivitis

(2009) Marguerite B. McDonald et al.   OPHTHALMOLOGY

Ocular TRUST: Nationwide Antimicrobial Susceptibility Patterns in Ocular Isolates

(2008) Penny A. Asbell et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Benzalkonium Chloride Enhances the Antibacterial Efficacy of Gatifloxacin in an Experimental Rabbit Model of Intrastromal Keratitis

(2008) Eric G. Romanowski et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Update on Bacterial Conjunctivitis in South Florida

(2007) Kara Cavuoto et al.   OPHTHALMOLOGY